Stock Movers Meta Jumps, Eli Lilly Drops, Kohl's Rises After Firing CEO
May 1, 2025
Meta's stock skyrocketed as strong advertising sales dispelled fears about the trade war and fueled AI expansion plans. Meanwhile, Eli Lilly faced a setback after CVS dropped its weight-loss drug Zepbound, leading to a stock decline and reduced earnings outlook. In a surprising twist, Kohl's shares surged after the abrupt firing of its CEO over questionable business dealings, with an interim replacement stepping in as the company searches for a new leader.
AI Snips
Chapters
Transcript
Episode notes
Meta's Ad Revenue Fuels AI
- Meta's advertising business makes up 98% of its revenue and is critical for funding AI expansion.
- Strong Q1 sales beat expectations, easing concerns about trade war impacts and macro uncertainty.
Eli Lilly Faces Competitive Pressure
- Eli Lilly's shares fell due to a disappointing earnings report and lower earnings outlook.
- CVS plans to increase distribution of Wegovy, a rival weight-loss drug, pressuring Eli Lilly's market position.
Kohl's CEO Firing Boosts Stock
- Kohl's fired its CEO after misconduct involving personal business relationships was discovered.
- Surprisingly, the stock price rose on the news, reflecting investor optimism for leadership change.